I got my calculator out last night and started to think that my free NIO shares could end up being worth more than my GNBT shares if NIO is bought by a big pharma. Barnard keeps throwing out numbers of other similar companies that were bought for billions, and had pre-clinical valuations of 1 billion. I'm too lazy right now to look up the names, but they are in his most recent articles.

The difference here though is that GNBT is holding onto an unknown percentage of the NIO spinoff.